Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%

Description

This is a clinical trial evaluating Ketorolac levels in vitreous and aqueous humor samples from patients undergoing combined cataract and pars plana vitrectomy surgeries with and without intracameral phenylephrine 1.0% / ketorolac 0.3% (OMIDRIA). Patients not receiving intracameral OMIDRIA will receive topical ketorolac prior to cataract surgery/pars plana vitrectomy.

Conditions

Cataract

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a clinical trial evaluating Ketorolac levels in vitreous and aqueous humor samples from patients undergoing combined cataract and pars plana vitrectomy surgeries with and without intracameral phenylephrine 1.0% / ketorolac 0.3% (OMIDRIA). Patients not receiving intracameral OMIDRIA will receive topical ketorolac prior to cataract surgery/pars plana vitrectomy.

Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%

Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%

Condition
Cataract
Intervention / Treatment

-

Contacts and Locations

Westbury

Ophthalmic Consultants of Long Island, Westbury, New York, United States, 11590

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Able to provide informed consent
  • 2. Undergoing cataract surgery immediately followed by pars plana vitrectomy
  • 3. Diagnosed preoperatively with a structural pathology requiring vitrectomy (e.g., epiretinal membrane, macular hole, and symptomatic vitreous floaters)
  • 4. Willing and able to comply with all study procedures
  • 5. Male or female, aged ≥ 18 years
  • 1. Age \< 18
  • 2. Participating in another clinical trial
  • 3. Patients undergoing cataract surgery or pars plana vitrectomy alone (not a combined procedure)
  • 4. Previous vitrectomy
  • 5. Complications at the time of cataract surgery
  • 6. A tear in the posterior capsule

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

DHS Consulting,

Eric Donnenfeld, MD, PRINCIPAL_INVESTIGATOR, Ophthalmic Consultants of Long Island

Study Record Dates

2026-02